Tumors with diminished formation of the CXCL12–KRT19 coating showed increased numbers of infiltrating CD3+ T cells (Fig. 5A) and slower growth rates than the tumors formed with PDA cells expressing TGM2 in both types of hosts (Fig. 5B). Here, TGM2 is linked to Patent ductus arteriosus.